GIMV NV (GIMB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.025x

Based on the latest financial reports, GIMV NV (GIMB) has a cash flow conversion efficiency ratio of -0.025x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-50.17 Million ≈ $-58.66 Million USD) by net assets (€1.98 Billion ≈ $2.32 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

GIMV NV - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how GIMV NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GIMV NV debt and liabilities for a breakdown of total debt and financial obligations.

GIMV NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GIMV NV ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CMST Development Co Ltd
SHG:600787
0.045x
Com7 PCL
BK:COM7
0.200x
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
0.014x
Thanachart Capital Public Company Limited
BK:TCAP-R
0.021x
Guangdong Ellington Electronics Technology Co Ltd
SHG:603328
0.053x
CLARIVATE PLC
NYSE:CLVT
0.033x
Ardelyx Inc
NASDAQ:ARDX
0.002x
RAPT Therapeutics Inc
NASDAQ:RAPT
-0.082x

Annual Cash Flow Conversion Efficiency for GIMV NV (2007–2025)

The table below shows the annual cash flow conversion efficiency of GIMV NV from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see how much is GIMV NV worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 €1.91 Billion
≈ $2.23 Billion
€-50.95 Million
≈ $-59.57 Million
-0.027x -100.17%
2024-03-31 €1.49 Billion
≈ $1.74 Billion
€-19.88 Million
≈ $-23.24 Million
-0.013x +61.57%
2023-03-31 €1.33 Billion
≈ $1.55 Billion
€-46.04 Million
≈ $-53.82 Million
-0.035x -23.58%
2022-03-31 €1.42 Billion
≈ $1.67 Billion
€-40.05 Million
≈ $-46.83 Million
-0.028x -2.94%
2021-03-31 €1.30 Billion
≈ $1.52 Billion
€-35.60 Million
≈ $-41.63 Million
-0.027x -16.47%
2020-03-31 €1.12 Billion
≈ $1.31 Billion
€-26.35 Million
≈ $-30.81 Million
-0.023x +10.96%
2019-03-31 €1.35 Billion
≈ $1.58 Billion
€-35.48 Million
≈ $-41.48 Million
-0.026x -2.85%
2018-03-31 €1.34 Billion
≈ $1.57 Billion
€-34.31 Million
≈ $-40.11 Million
-0.026x +19.06%
2017-03-31 €1.28 Billion
≈ $1.50 Billion
€-40.46 Million
≈ $-47.30 Million
-0.032x -43.07%
2016-03-31 €1.20 Billion
≈ $1.40 Billion
€-26.42 Million
≈ $-30.89 Million
-0.022x +19.57%
2015-03-31 €1.12 Billion
≈ $1.31 Billion
€-30.74 Million
≈ $-35.94 Million
-0.027x -84.39%
2014-03-31 €1.00 Billion
≈ $1.17 Billion
€-14.95 Million
≈ $-17.48 Million
-0.015x -310.69%
2013-03-31 €1.02 Billion
≈ $1.19 Billion
€7.22 Million
≈ $8.44 Million
0.007x -96.89%
2012-03-31 €1.04 Billion
≈ $1.21 Billion
€235.93 Million
≈ $275.83 Million
0.227x +597.50%
2011-03-31 €1.07 Billion
≈ $1.25 Billion
€34.74 Million
≈ $40.62 Million
0.033x -42.77%
2010-03-31 €1.01 Billion
≈ $1.18 Billion
€57.38 Million
≈ $67.09 Million
0.057x +165.24%
2009-03-31 €905.27 Million
≈ $1.06 Billion
€-79.01 Million
≈ $-92.38 Million
-0.087x -349.18%
2008-03-31 €1.32 Billion
≈ $1.54 Billion
€46.07 Million
≈ $53.86 Million
0.035x +248.94%
2007-03-31 €1.26 Billion
≈ $1.47 Billion
€-29.62 Million
≈ $-34.63 Million
-0.024x --

About GIMV NV

BR:GIMB Belgium Asset Management
Market Cap
$2.07 Billion
€1.77 Billion EUR
Market Cap Rank
#6921 Global
#35 in Belgium
Share Price
€48.00
Change (1 day)
+0.42%
52-Week Range
€40.75 - €49.30
All Time High
€49.30
About

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, pre-revenue, middle market, debt, shareholder loans, seed, startups, early to mid-stage, mezzanine, late venture, emerging growth, public to private transactions, small and medium sized enterprises, later stage, mature,… Read more